Empower Clinics Inc. is launching a pilot program with Cannvas MedTech to place educational kiosks in each of the Empower clinics to advance the education of patients, collection of data and analysis of physician recommended alternative CBD based therapies.
VANCOUVER B.C.: APRIL 18, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company”), a growth oriented, diversified health and wellness company, is pleased to announce that it intends to partner with Cannvas MedTech Inc. (“Cannvas”) (CSE: MTEC) (FRA: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, to create a pilot to launch a comprehensive education, data collection and analysis program starting with the installation of a network of standalone on-site Cannvas educational kiosks in the Empower network of medical clinics.
“This is an opportunity to bring unbiased cannabis education to a large population of patients looking for therapies to alleviate a number of ailments while also learning more about what behaviours may drive the decision to look at cannabis as an alternative or complementary treatment,” said Shawn Moniz, Chief Executive Officer, Cannvas. “We are thrilled to partner with Empower Clinics to couple cannabis education with data analysis and better serve their patients while growing the Cannvas brand across the United States.”
It is expected that Cannvas will place its Cannvas kiosks throughout Empower’s network of clinics to provide accessible and unbiased cannabis education to Empower’s patients, integrating geo-targeting capabilities to ensure relevant contextual information across the country. Cannvas will be a key data and analytics partner for Empower by providing meaningful insights on customer behaviours and industry trends and integrating mutually beneficial existing data partnerships.
“In recent weeks, the Company has been re-positioning its overall strategy to become a vertically integrated health and wellness company that connects to its 120,000 patients using a data driven focus to improve patients’ lives with products, technology and health systems”, stated Steven McAuley, Empower CEO, “the addition of the Cannvas educational kiosks, a user friendly and highly interactive education platform, is a tremendous step forward to making our brand one of the go to sources for content for both patients and the medical community nationwide.”
Every month Empower hosts informational sessions about alternative treatment options and the potential health benefits with doctors and staff available to answer questions. It is expected that Cannvas will play an active role in the review and implementation of new educational curriculum based on original content from Cannvas website, Cannvas.me.
The Company also plans to begin further pilot initiatives with Cannvas to provide content and educational links to Cannvas.me and Cannvas.health directly from the new Empower website www.empowerclinics.com and through the Empower tele-medicine portal.
ABOUT EMPOWER
Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. It is expected that Empower’s proprietary product line “Sollievo” will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based products in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.
ABOUT CANNVAS MEDTECH
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.
For French inquiries: Remy Scalabrini, Maricom Inc., E: rs@maricom.ca, T: (888) 585-6274
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steve Low
Boom Capital Markets
647-620-5101
For French inquiries: Remy Scalabrini, Maricom Inc., E: rs@maricom.ca, T: (888) 585-6274
Investors:
Steven McAuley
CEO
s.mcauley@wordpress-776017-3222400.cloudwaysapps.com
604-789-2146
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding the launch of a pilot program with Cannvas, the placement of kiosks in the Company’s clinics, the effect of the placement of kiosks in the Company’s clinics, the effect of Cannvas as a partner of the Company, the role of Cannvas in connection with monthly informational sessions, future pilot initiatives, the effect of the Company’s product line “Sollievo”, the benefits of CBD based products, and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the proposed partnership may not be completed or have the expected effect; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.